Additionally, reduced NOX2 activity seemed to improve glucose tolerance, reduce hyperlipidemia, and reduce adipose inflammation following obesity to some degree, in accordance with previous studies [30,36]. This evidence concerns the gene CYBB and obesity due to melanocortin 4 receptor deficiency.